SEC Form 4 · accession 0000899243-17-019280
ANAPTYSBIO, INC · ANAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Kevin J Kinsella
10% Owner · Other
Avalon Ventures VII L P
10% Owner
AVALON VENTURES VII GP, LLC
10% Owner · Other
Stephen Lawrence Tomlin
10% Owner · Other
Period of report
Jul 26, 2017
Accepted (ET)
Jul 28, 2017 · 3:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001370053
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 26, 2017 | J | 399,987 | $0.00 | D | 1,636,945 | I | See footnote |
| Common StockF2 | Jul 26, 2017 | J | 37,040 | $0.00 | A | 37,040 | I | See footnote |
| Common StockF3 | Jul 26, 2017 | S | 37,040 | $24.35 | D | 0 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a pro-rata in-kind distribution of Common Stock by Avalon Ventures VII, L.P. effected on July 26, 2017 without consideration to its limited partners and to its general partner, Avalon Ventures VII GP, LLC.
- F2Represents the receipt by Avalon Ventures VII GP, LLC, the general partner of Avalon Ventures VII, L.P., of its pro-rata portion of the in-kind distribution described in footnote 1.
- F3Represents the open-market sale by Avalon Ventures VII GP, LLC, the general partner of Avalon Ventures VII, L.P., of the Common Stock received as a result of the in-kind distribution described in footnote 1.
Remarks
Avalon Ventures VII GP, LLC is the general partner of Avalon Ventures VII, L.P. The managing members of Avalon Ventures VII GP, LLC are Kevin J. Kinsella and Stephen L. Tomlin. As a result of the transactions reported herein, none of the Reporting Owners will beneficially own 10% or greater of the outstanding Common Stock or otherwise be subject to Section 16 (except as expressly provided by Section 16 once reporting status has ended).